Cargando…
Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
Hyperglycaemia can strongly alter the epigenetic signatures in many types of human vascular cells providing persistent perturbations of protein–protein interactions both in micro- and macro-domains. The establishment of these epigenetic changes may precede cardiovascular (CV) complications and help...
Autores principales: | Napoli, Claudio, Benincasa, Giuditta, Schiano, Concetta, Salvatore, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363021/ https://www.ncbi.nlm.nih.gov/pubmed/31665258 http://dx.doi.org/10.1093/ehjcvp/pvz062 |
Ejemplares similares
-
Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010) -
Future Prospects for Epigenetics in Autism Spectrum Disorder
por: Williams, Logan A., et al.
Publicado: (2022) -
Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
por: Bello, Alfonso E., et al.
Publicado: (2014) -
Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential
por: Cecil, Charlotte A. M., et al.
Publicado: (2022) -
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)